As of April 11, 2026, Apimeds Pharmaceuticals US's top three insider holders are Inc. Inscobee (TenPercentOwner, 4.39Mn shares), Inc. Inscobee (TenPercentOwner, 2.10Mn shares), Jakap Koo (Director, 643.88K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Inc. Inscobee | - | 0 | 4,387,708 | 14 May, 2025 |
| Inc. Inscobee | - | 2,099,747 | 0 | 11 Jun, 2025 |
| Jakap Koo | - | 643,885 | 0 | 14 May, 2025 |
| Christopher Kim | Chairman And Cmo | 277,500 | 0 | 20 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Nov, 2025 | Carol A O'Donnell | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Jakap Koo | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 15 Oct, 2025 | Carol A O'Donnell | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Jakap Koo | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Christopher Kim | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 12 May, 2025 | Inc. Inscobee | Common Stock, par value $0.01 per share | A | 71,090 | $2.60 | 2,055,706 | D | C |
| 12 May, 2025 | Inc. Inscobee | Common Stock, par value $0.01 per share | A | 44,041 | $2.60 | 2,099,747 | D | C |
| 16 May, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 5,780 | $0.00 | 5,780 | D | A |
| 16 May, 2025 | Jakap Koo | Stock Option (right to buy) | A | 5,780 | $0.00 | 5,780 | D | A |
| 16 May, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 5,780 | $0.00 | 5,780 | D | A |
| 16 May, 2025 | Christopher Kim | Common Stock, par value $0.01 per share | A | 250,000 | $0.00 | 277,500 | D | A |
| 16 May, 2025 | Carol A O'Donnell | Stock Option (right to buy) | A | 5,780 | $0.00 | 5,780 | D | A |
| 13 May, 2025 | Christopher Kim | Common Stock, par value $0.01 per share | A | 19,770 | $1.82 | 19,770 | D | P |
| 14 May, 2025 | Christopher Kim | Common Stock, par value $0.01 per share | A | 7,730 | $1.86 | 27,500 | D | P |
| 12 May, 2025 | Jakap Koo | Common Stock, par value $0.01 per share | A | 28,500 | $1.99 | 643,885 | D | P |
| 12 May, 2025 | Inc. Inscobee | Common Stock, par value $0.01 per share | A | 500,000 | $4.00 | 1,984,616 | D | P |